Ishares Gen-immunology Hlth (IDNA) Technical Analysis
$24.89▲1.47%
Market is closed - opens 7 PM, 27 Oct 2025
Insights
- Ishares Gen-immunology Hlth is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Ishares Gen-immunology Hlth stock suggests that it is range bound and no decision can be made based on this information
- Based on analysis of the Moving Averages technical indicator, Ishares Gen-immunology Hlth stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for Ishares Gen-immunology Hlth stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 59.18 | Neutral |
Stochastic | 65.56, 50.14 | Neutral |
Ultimate Oscillator | 52.23 | Neutral |
Stochastic Relative Strength Index | 8.05, 16.98 | Neutral |
Moving Average Convergence Divergence | 0.44, 0.48 | Sell |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 24.72 | Buy |
20 | 24.49 | Buy |
50 | 23.4 | Buy |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 24.68 | Buy |
20 | 24.37 | Buy |
50 | 23.54 | Buy |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 24.67 | Neutral |
20 | 24.54 | Neutral |
50 | 23.78 | Neutral |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 24.9 | Sell |
20 | 24.99 | Buy |
50 | 24.67 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 24.8 | Sell |
20 | 25.01 | Buy |
50 | 25.01 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 24.72 |
Resistance L2 | 24.67 |
Resistance L1 | 24.6 |
Pivot Point | 24.55 |
Support L1 | 24.48 |
Support L2 | 24.43 |
Support L3 | 24.36 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.